No information is available on the clinical use of abemaciclib during breastfeeding. Because abemaciclib and its metabolites are over 90% bound to plasma proteins, the amount in milk is likely to be low. However, the manufacturer recommends that breastfeeding be discontinued during abemaciclib therapy and for 3 weeks after the final dose.
关于阿贝西利在母乳喂养期间的临床应用尚无可用信息。由于阿贝西利及其代谢产物与血浆蛋白的结合率超过90%，乳汁中的含量可能较低。然而，制造商建议在阿贝西利治疗期间及最后一剂后3周内停止母乳喂养。
